BCV
ALXN

Banque Cantonale Vaudoise’s Alexion Pharmaceuticals ALXN Stock Holding History

Banque Cantonale Vaudoise’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-131
Closed -$24K – 1390
2021
Q2 		$24K Sell
131
-48
-27% -$8.24K ﹤0.01% 1148
2021
Q1 		$27K Sell
179
-3,123
-95% -$483K ﹤0.01% 1057
2020
Q4 		$515K Sell
3,302
-2,263
-41% -$291K 0.03% 487
2020
Q3 		$636K Buy
5,565
+438
+9% +$47.3K 0.04% 375
2020
Q2 		$576K Buy
5,127
+790
+18% +$83.9K 0.04% 353
2020
Q1 		$388K Sell
4,337
-68
-2% -$6.67K 0.03% 429
2019
Q4 		$476K Buy
+4,405
New +$471K 0.03% 480

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return